So the Capex requirement for each stage is as follows:
- Stage 1 - 62% DSO - $12m
- Stage 2 - 65% Fines - $20m
- Stage 3 - 68% Concentrate - $150m
- Stage 4 - HISMELT - $150m
Margins are as follows:
- 62% DSO - $67 in 2021-22
- 65% Fines - $87 in 2021-22, $47 for 2022-23, $27 for 2023-24 onwards
- 68% Concentrate - $69 for 2022-23, $59 for 2023-24 onwards
- HISMELT - $170
If MGU, only ever did upto stage 2 (65% fines), so a Capex cost of $32m, it would have the following EBITDA.
- 2021-22 (250kt @ 62%, 40kt @65%) - $20.2m
- 2022-23 (2.4mt@ 65%) - $112.8m
- 2023-24 (steady state) (2.4mt @65%) - $65m
NPV based on this would be around $600m. That alone is close to 10x upside. I have assumed no dilution in this scenario as operating cashflows could find Capex.
If MGU, only ever did upto stage 3 (68% concentrate), so a Capex cost of $182m, it would have the following EBITDA.
- 2021-22 (250kt @ 62%, 40kt @65%) - $20.2m
- 2022-23 (960kt @ 65%, 1,140kt @68%) - $123.8m
- 2023-24 (steady state) (960kt @65%, 1,440kt @68%) - $110.9m
NPVbased on this would be around $1 billion. This will mean a share price of around $1.45 which is 12x upside (taking into account dilution for the concentrate plant)
I went through the HISMELT scenario before which had a NPV close to $1.7 billion and close to a $2.50 share price, which is a 20x upside from here.
A lot of this analysis is predicated on fairly low cost and iron ore prices staying around the $100 mark long term. It will be interesting to see what the actual cost comes in at.
We are using a 62% FOB cost of $46. MGT in its recent PFS had a 62% break even price of $54, so the number I am using could be a bit too low.
Any thoughts or feedback would be great.
- Forums
- ASX - By Stock
- MGU
- Ann: Anglo American Agreement
Ann: Anglo American Agreement, page-56
-
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MGU (ASX) to my watchlist
|
|||||
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $11.33M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.4¢ | $28.85K | 2.053M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 450000 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 542751 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 450000 | 0.013 |
5 | 3015448 | 0.012 |
9 | 1560909 | 0.011 |
14 | 1654285 | 0.010 |
4 | 801200 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 512751 | 3 |
0.016 | 700000 | 2 |
0.017 | 472407 | 4 |
0.018 | 148041 | 2 |
0.019 | 200000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MGU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online